Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Operating expenses:
Research and development expenses	$ 5,647,798	$ 1,089,177	$ 8,163,825	$ 2,642,537
General and administrative expenses	3,629,090	1,304,527	9,326,604	2,679,618
Loss from operations	(9,276,888)	(2,393,704)	(17,490,429)	(5,322,155)
Other income (expenses):
Interest expense	(2,954)	(2,302,174)	(8,098)	(4,635,013)
Other income	898	0	1,601	0
Change in fair value of liability		0	532,353	0
Total other income (expenses)	(2,056)	(2,302,174)	525,856	(4,635,013)
Net loss-	(9,278,944)	(4,695,878)	(16,964,573)	(9,957,168)
Other comprehensive loss:
Foreign currency translation adjustment	21,840	(163,719)	(112,957)	(6,225)
Total comprehensive loss	(9,257,104)	(4,859,597)	(17,077,530)	(9,963,393)
Net loss	(9,278,944)	(4,695,878)	(16,964,573)	(9,957,168)
Deemed dividend on preferred stock issuances	0	0	(4,507,125)	0
Deemed dividend on preferred stock exchanges	(3,424,205)	0	(21,008,253)	0
Preferred stock dividends	(26,661)	0	(231,043)
Net loss applicable to common shareholders	$ (12,729,810)	$ (4,695,878)	$ (42,710,994)	$ (9,957,168)
Basic and diluted weighted average shares outstanding	78,124,399	28,016,478	66,799,183	27,479,140
Loss per share - basic and diluted	$ (0.16)	$ (0.17)	$ (0.64)	$ (0.36)